Fulgent to Participate in Upcoming Conferences
Fulgent Genetics (NASDAQ:FLGT) has announced its management team's upcoming participation in two major healthcare conferences. The company will present at the UBS Global Healthcare Conference on November 12th at 2:45 PM Pacific Time and the Piper Sandler 36th Annual Healthcare Conference on December 4th at 11:30 AM Eastern Time.
Live webcasts of both presentations will be available on Fulgent's Investor Relations website, with replay options accessible approximately one hour after each event concludes.
Fulgent Genetics (NASDAQ:FLGT) ha annunciato la partecipazione del suo team di gestione a due importanti conferenze nel settore sanitario. L'azienda presenterà alla UBS Global Healthcare Conference il 12 novembre alle 14:45, ora del Pacifico, e alla Piper Sandler 36th Annual Healthcare Conference il 4 dicembre alle 11:30, ora orientale.
Le trasmissioni web in diretta di entrambe le presentazioni saranno disponibili sul sito delle Relazioni con gli Investitori di Fulgent, con opzioni di replay accessibili circa un'ora dopo la conclusione di ciascun evento.
Fulgent Genetics (NASDAQ:FLGT) ha anunciado la próxima participación de su equipo de gestión en dos importantes conferencias de salud. La empresa presentará en la UBS Global Healthcare Conference el 12 de noviembre a las 14:45 hora del Pacífico y en la Piper Sandler 36th Annual Healthcare Conference el 4 de diciembre a las 11:30 hora del Este.
Se podrán ver las transmisiones en vivo de ambas presentaciones en el sitio web de Relaciones con Inversores de Fulgent, con opciones de repetición disponibles aproximadamente una hora después de que concluyan los eventos.
Fulgent Genetics (NASDAQ:FLGT)는 경영진이 두 개의 주요 헬스케어 컨퍼런스에 곧 참여할 것이라고 발표했습니다. 이 회사는 11월 12일 태평양 표준시로 오후 2시 45분에 UBS Global Healthcare Conference에서 발표하며, 12월 4일 동부 표준시로 오전 11시 30분에 Piper Sandler 36th Annual Healthcare Conference에 참여할 것입니다.
두 발표의 생중계는 Fulgent의 투자자 관계 웹사이트에서 확인할 수 있으며, 각 이벤트 종료 후 약 1시간 정도 지나면 재생 옵션도 제공합니다.
Fulgent Genetics (NASDAQ:FLGT) a annoncé la prochaine participation de son équipe de direction à deux grandes conférences sur la santé. L'entreprise se présentera à la UBS Global Healthcare Conference le 12 novembre à 14h45, heure du Pacifique, et à la Piper Sandler 36th Annual Healthcare Conference le 4 décembre à 11h30, heure de l'Est.
Des retransmissions en direct des deux présentations seront disponibles sur le site des Relations Investisseurs de Fulgent, avec des options de rediffusion accessibles environ une heure après la fin de chaque événement.
Fulgent Genetics (NASDAQ:FLGT) hat die bevorstehende Teilnahme seines Management-Teams an zwei wichtigen Gesundheitskonferenzen angekündigt. Das Unternehmen wird am 12. November um 14:45 Uhr pazifischer Zeit bei der UBS Global Healthcare Conference präsentieren und am 4. Dezember um 11:30 Uhr östlicher Zeit bei der Piper Sandler 36th Annual Healthcare Conference.
Livestreams beider Präsentationen sind auf der Investor-Relations-Website von Fulgent verfügbar, mit Wiedergabeoptionen, die etwa eine Stunde nach dem Ende jeder Veranstaltung zugänglich sind.
- None.
- None.
- UBS Global Healthcare Conference on Tuesday, November 12th at 2:45 PM Pacific Time
- Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4th at 11:30 AM Eastern Time
Live webcasts of the sessions will be available on the Investor Relations section of the Fulgent website at ir.fulgentgenetics.com. Replay of the webcasts will be accessible at the same location beginning approximately one hour following the completion of the event.
About Fulgent
Fulgent is a technology-based company with a well-established laboratory services business and a therapeutic development business. Fulgent’s laboratory services business, which was formerly referred to as the clinical diagnostic business, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Fulgent’s therapeutic development business is focused on developing drug candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The Company aims to transform from a genomic diagnostic business into a fully integrated precision medicine company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241105488393/en/
Investor Relations Contact:
The Blueshirt Group
Melanie Solomon, melanie@blueshirtgroup.com
Source: Fulgent Genetics, Inc.
FAQ
When is Fulgent Genetics (FLGT) presenting at the UBS Global Healthcare Conference 2023?
What time is Fulgent's (FLGT) presentation at the Piper Sandler Healthcare Conference?
Where can I watch Fulgent Genetics' (FLGT) conference presentations?
How long after the conferences will Fulgent (FLGT) make the replay available?
